Biostatus Ltd. Release: Spheroid Imaging Mountant

Shepshed, LEICS., UK August 31st, 2010 -- The thermo-reversible mountant CyGEL™ (Biostatus Ltd., UK) enables high resolution imaging of live 3D tumor spheroids cultured in low-adherence conditions and without fixation or cytospin centrifugation. A recent paper by Fredika M. Robertson, et al., Imaging and Analysis of 3D Tumor Spheroids Enriched for a Cancer Cell Phenotype. J Biomol Screen. 2010 15:820-829, confirms that CyGEL™ stabilizes multicellular structures for imaging and characterization, whilst retaining cellular viability, morphology and protein expression. CyGEL™ is optically inert and clear, compatible with fluorescence and permits delivery of organelle-specific and viability probes. Objects can be isolated, imaged and then easily recovered for orthogonal analysis. CyGEL™ allows a breadth of advanced microscopic techniques for live-cell imaging of both mammalian and non-mammalian structures.

Biostatus Ltd. +44 (0)1509 558163 enquiry@biostatus.com Hyperlink: http://www.biostatus.com/news/high_quality_tumor-spheroid_imaging/

CONTACT:

Roy Edward Sales & Mktg. Director, Biostatus Ltd TEL: +44(0)1509 558163; roy@biostatus.com; www.biostatus.com Co. 3079239. Regd. in England & Wales. Regd. office: 56 Charnwood Road, Shepshed, LE12 9NP, UK.

MORE ON THIS TOPIC